logo-large
  • Browse Categories

Publications by authors named "Keyou Xu"

Claim this Profile
A
A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.
Jun Mou, Min Zhang, Fumin Qin, Yajie Cui, Keyou Xu, Kai Xu

Front Immunol· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation.
Yaru Huang, Xiaotong Sun, Zhaodong Juan, Rui Zhang, Ruoguo Wang, Keyou Xu

BMC Anesthesiol· May 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation.
Yaru Huang, Xiaotong Sun, Zhaodong Juan, Rui Zhang, Ruoguo Wang, Keyou Xu

BMC Anesthesiol· April 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapeutic Effects of Lishengsu on Chemotherapy Induced Leukopenia in Patients with Malignant Tumor].
Zheng Xu, Ke-You Xu, Tao Liu

Zhongguo Shi Yan Xue Ye Xue Za Zhi· March 2001


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: